FDA finds little evidence that a generic drug can help people with autism
ABC News
The FDA is approving a generic drug for a very rare genetic disorder, but not for autism
WASHINGTON -- The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that the drug showed great promise for people with autism.
The agency said it approved leucovorin for children and adults with a genetic condition that limits delivery of folate, a form of vitamin B, to the brain. FDA officials estimate the ultrarare condition impacts fewer than 1 in a million people in the U.S.
It's a major step back from statements made at a White House news conference in September, when Trump and FDA commissioner Marty Makary announced the drug was under review to benefit patients with autism, some of whom have a form of the vitamin brain deficiency.
“It might be 20, 40, 50% of kids with autism,” Makary said at the news conference.
The White House event followed promises from Health Secretary Robert F. Kennedy Jr. to determine the cause of autism by September.
Rural school districts say the Trump administration’s visa changes are jeopardizing a key source of teachers
Cuba is grappling with a fast-growing wave of synthetic drug use that is hitting young people hard
An old NASA science satellite is no more
Stryker, a U.S. medical equipment company, says a cyberattack has disrupted its global networks
Virginia senators are pushing to curtail a 5.3% tax break for data centers
The Iran war is testing America's ability to combat swarms of cheap drones that have become a staple of the modern battlefield after Ukraine and Russia demonstrated how effective they can be
Hawaii's Kilauea volcano is shooting lava fountains up to 1,000 feet, and falling ash and volcanic fragments are forcing temporary closures on the Big Island
Meta is acquiring Moltbook, a social network where AI agents post and chat with each other
The FDA is approving a generic drug for a very rare genetic disorder, but not for autism
A new study in the journal Nature Cities shows that as temperatures rise aboveground, the number of subway riders reporting uncomfortable heat belowground increases
Tomoko Kobayashi reopened her inn in northeastern Fukushima to bring a sense of normal life back to her deserted hometown five years after the nuclear disaster
French President Emmanuel Macron is traveling to Cyprus
Bigger and bigger data centers are leading to proposals for massive electric power transmission lines, sometimes across hundreds of miles